Sallie Mae Reports First-Quarter 2024 Financial Results
Get Alerts SLM Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 1.7%
EPS Growth %: +53.1%
Join SI Premium – FREE
NEWARK, Del.--(BUSINESS WIRE)-- Sallie Mae (Nasdaq: SLM), formally SLM Corporation, today released first-quarter 2024 financial results. Complete financial results and related materials are available at www.SallieMae.com/investors. The materials will also be available on the Securities and Exchange Commission’s website at www.sec.gov.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240424661958/en/
Sallie Mae will host an earnings conference call today, April 24, 2024, at 5:30 p.m. ET. Executives will be on hand to discuss various highlights of the quarter and to answer questions related to Sallie Mae’s performance. A live audio webcast of the conference call and presentation slides may be accessed at www.SallieMae.com/investors and the hosting website.
A replay of the webcast will be available via the company’s investor website approximately two hours after the call’s conclusion.
Sallie Mae (Nasdaq: SLM) believes education and life-long learning, in all forms, help people achieve great things. As the leader in private student lending, we provide financing and know-how to support access to college and offer products and resources to help customers make new goals and experiences, beyond college, happen. Learn more at SallieMae.com. Commonly known as Sallie Mae, SLM Corporation and its subsidiaries are not sponsored by or agencies of the United States of America.
Category: Corporate and Financial
View source version on businesswire.com: https://www.businesswire.com/news/home/20240424661958/en/
Media
Rick Castellano, 302-451-2541, [email protected]
Investors
Melissa Bronaugh, 571-526-2455, [email protected]
Source: Sallie Mae
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- NVE Corporation names new CEO and expands board to seven members
- Pfizer lung cancer drug misses survival goal in Phase 3 trial
- Seadrill extends $500M share repurchase program to end of 2026
Create E-mail Alert Related Categories
Business Wire, Press ReleasesRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share